NASDAQ:KALA

Kala Pharmaceuticals Earning Date

USA |NASDAQ |USD

KALA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.42 $-0.48 $-0.50
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $5.31M $3.05M $2.22M

Kala Pharmaceuticals's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

KALA Earnings Date & History Chart

KALA Earnings & Revenue Forecast

KALA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.39 $-0.47 $-0.31
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.84 $-1.98 $-1.63
Dec 2022 4 $-1.22 $-1.36 $-1.10

KALA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.39 $-0.39 $-0.38
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.84 $-1.84 $-1.77
Dec 2022 0 / 0 $-1.22 $-1.22 $-0.97

KALA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $8.52M $4.10M $11.36M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $19.98M $14.00M $23.93M
Dec 2022 7 $65.48M $36.20M $87.00M

KALA Earnings Date & Revenue History

KALA Earnings History

|
Show More
Show More

KALA Revenue History

|
Show More
Show More

Kala Pharmaceuticals Next Earnings Date & Report

KALA Next Earnings Date & Report Preview: Sep 2021 (FQ)

KALA's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Kala Pharmaceuticals's next quarterly earnings is $-0.42, with a low EPS estimation of $-0.47, and a high estimation of $-0.36.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.42, the last 2 month trend is $-0.42, and the 3 month trend is $-0.44.

Based on 5 analysts, the average revenue estimation is $5.31M, with a low revenue estimation of $3.50M, and a high estimation of $6.26M.

Kala Pharmaceuticals Previous Earnings Dates & Reports

KALA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Kala Pharmaceuticals's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

KALA's earnings per share (EPS) was $-0.48, missing the consensus analysts forecast of $-0.44 by -9.48%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -1.67%, and lower than the same period a year before (Jun 2020) by 14.71%.

Revenues were $3.05M, worse than the forecast of $5.25M by -41.89%, down by -6.58% from the previous quarter , and up by 266.27% from the same period last year.

The company reported a net income of $-36.50M.

Free cash flow for the quarter was $-21.93M , compared to $-32.86M last quarter and $-19.88M a year before.

KALA ended the quarter with $107.09M in total debt, an increase of 43.74% compared to the previous quarter, and a decrease of -16.48% compared to the same quarter a year before.

KALA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Kala Pharmaceuticals's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

KALA's earnings per share (EPS) was $-2.01, missing the consensus analysts forecast of $-1.92 by 4.69% , and higher than the previous year's EPS (Dec 2019) by -27.17%.

Revenues were $6.36M, worse than the forecast of $6.43M by -1.06%, and up by 4.74% from previous year's revenue.

The company reported a net income of $-104.33M.

Kala Pharmaceuticals reported a free cash flow of $-92.64M for its fiscal year, compared to $-94.06M a year ago.

The company ended the fiscal year with $73.77M in total debt, an increase of 1.74% compared to the previous year.